The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer

Zheng Li-e; Qu Jun-ying; He Fei

doi:10.1515/med-2016-0024

Open Medicine (Jan 2016)

The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer

Zheng Li-e,
Qu Jun-ying,
He Fei

Affiliations

Zheng Li-e: The First Affliliated Hospital Of Fujian Medical University, Chazhong Road 22, Fuzhou, Fujian 350001, People’s Republic of China, Tel:0591-87982062, Fujian Medical University 350004, China
Qu Jun-ying: Department of obstetrics and gynecology, the First Affliliated Hospital Of Fujian Medical University, Fujian Fuzhou 350005, China; Fujian Medical University 350004, China
He Fei: Department of obstetrics and gynecology, the First Affliliated Hospital Of Fujian Medical University, Fujian Fuzhou 350005, China; Fujian Medical University 350004, China

DOI: https://doi.org/10.1515/med-2016-0024
Journal volume & issue: Vol. 11, no. 1
pp. 125 – 132

Abstract

Read online

To evaluate the value of individual and combined measurement of human epididymis protein 4 (HE4) and cancer antigen 125 (CA-125) in the diagnosis of ovarian cancer.

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords